Veracyte, Inc. - Common Stock (VCYT)

Veracyte Inc. is a leading biotechnology company focused on advancing genomic medicine to improve patient care in oncology and other diseases

The company specializes in developing innovative diagnostic solutions that enhance the accuracy of clinical decision-making, particularly in the evaluation of thyroid nodules, lung cancer, and other conditions where traditional tissue biopsy can be inconclusive or invasive. By leveraging advanced genomic technology and a platform of proprietary tests, Veracyte aims to provide physicians and patients with reliable information that can inform treatment choices and ultimately lead to better outcomes in personalized medicine.